Industry

− NorthStar is further expanding commercial-scale domestic radioisotope production capabilities using IBA’s environmentally preferable Rhodotron® accelerator technology – BELOIT, Wis. & LOUVAIN-LA-NEUVE, Belgium–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC (‘NorthStar’), a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and IBA (Ion Beam Applications S.A., EURONEXT), the world … [Read more…]

– AMVUTTRA Demonstrated Halting or Reversal in Neuropathy Impairment with Subcutaneous Administration Once Every Three Months – – Decision Follows Positive Opinion from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) in July 2022 – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that … [Read more…]

The Sensitive Skincare Faculty is a first-of-its-kind global community of experts dedicated to creating a better life for people with sensitive skin The Sensitive Skincare Faculty will focus on three core pillars of activities: research, innovation and engagement Two grants have been awarded to the George Washington University School of Medicine and Health Sciences to … [Read more…]

Start-up agreement is major step forward in readiness to conduct Phase 1b clinical trial of Company’s HOCl-based respiratory infection drug candidate, SPX-001 Partner and SpectrumX will align on detailed clinical trial protocol to discuss with the MHRA at Scientific Advisory Meeting, currently scheduled for 14 November 2022 LONDON–(BUSINESS WIRE)–SpectrumX, a UK-based healthcare and pharmaceutical company, … [Read more…]

SHANGHAI–(BUSINESS WIRE)–$CHINA #china–Acting as a major platform for international procurement, investment promotion, cultural exchanges and open cooperation, the China International Import Expo (CIIE) has been held for four consecutive years and is widely regarded as an international public good, which in turn is good for economic globalization and multilateral trading system. With a number of … [Read more…]

SEVENUM, Netherlands–(BUSINESS WIRE)–SHOP APOTHEKE EUROPE looks back on the successful opening of its new distribution centre in Milan, Italy. After the first package had left the site on July 4, the official inauguration ceremony took place last Friday along with the management and the Italian employees on site. As officially announced earlier this year, 100% … [Read more…]

Aims to combine NETRIS Pharma’s mAb with selected radioisotopes LYON, France–(BUSINESS WIRE)–NETRIS Pharma SAS, a private clinical-stage biopharmaceutical company, announced today that it has entered into a scientific collaboration agreement with Orano and the Centre Léon Bérard (CLB) to develop novel Antibody Radio-Conjugates for the treatment of cancer. Initially, the parties intend to conduct a … [Read more…]

GOSSELIES, Belgium & MONT-SAINT-GUIBERT, Belgium–(BUSINESS WIRE)–Cellistic, the cell therapy development and manufacturing business of Ncardia BV, and Celyad Oncology (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, announced today a transaction whereby Cellistic will acquire Celyad Oncology’s Good … [Read more…]

Over two thirds of customers are interested in physical and financial wellness, yet only 8% of insurers have established the necessary capabilities. PARIS–(BUSINESS WIRE)–Capgemini and Qorus’ inaugural World Life and Health Insurance Report, published today, reveals that customers consider insurers among the top two preferred providers1 for physical and financial wellness advice. However, most insurers … [Read more…]

Study of the Paradise™ Ultrasound Renal Denervation System Shows significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension TOKYO–(BUSINESS WIRE)–Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) a wholly owned subsidiary of Otsuka Holdings today announced the detailed results from the RADIANCE II US FDA IDE pivotal trial evaluating the endovascular Paradise™ Ultrasound Renal … [Read more…]